Literature DB >> 22098103

Comparison of clinical characteristics and management of inflammatory bowel disease in Hong Kong versus Melbourne.

Lani Prideaux1, Michael A Kamm, Peter De Cruz, James Williams, Sally J Bell, William R Connell, Steven J Brown, Mark Lust, Paul V Desmond, Heyson Chan, Dorothy K L Chow, Justin C Y Wu, Rupert W Leong, Joseph J Sung, Francis K L Chan, Siew C Ng.   

Abstract

BACKGROUND AND AIM: Inflammatory bowel disease (IBD), common in Melbourne, was rare but is now increasing in incidence in Hong Kong (HK). To investigate whether these are the same diseases in the West and East, potential causes of changing incidence, and to plan resource needs, an appreciation of clinical characteristics in contrasting populations is essential.
METHODS: Disease characteristics were collected from prospectively populated IBD databases in two specialist centers in Melbourne, Australia and HK.
RESULTS: Of 795 patients (Crohn's disease [CD] : ulcerative colitis [UC] Melbourne 272:159 and HK 161:203), the age of diagnosis was higher, there were proportionally more male patients with CD but no UC sex difference, fewer patients were current or ex-smokers (CD 8% vs 50%; UC 17% vs 35%) and a family history of IBD was less common (2% vs 11%; P < 0.001) in HK compared to Melbourne. Stricturing and perianal CD were more common in HK (12% vs 6%; P < 0.001; and 29% vs 16%; P = 0.001, respectively). In HK for UC, more patients had extensive disease at diagnosis (42% vs 22%) but colectomy was less common (7% vs 20%; P < 0.001). In Melbourne there was greater steroid use at diagnosis and patients were more likely to receive an immunomodulator or anti-tumor necrosis factor agent.
CONCLUSIONS: IBD in HK was diagnosed at an older age, and had more complicated disease behavior than in Melbourne. Medical therapy, however, was less intense in HK. These differences may relate to real differences in disease or delayed diagnosis due to late presentation and less disease recognition in HK.
© 2011 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22098103     DOI: 10.1111/j.1440-1746.2011.06984.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  13 in total

Review 1.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

2.  Inflammatory bowel disease in Asia.

Authors:  Siew C Ng
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-01

Review 3.  Crohn's disease.

Authors:  Giulia Roda; Siew Chien Ng; Paulo Gustavo Kotze; Marjorie Argollo; Remo Panaccione; Antonino Spinelli; Arthur Kaser; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Dis Primers       Date:  2020-04-02       Impact factor: 52.329

4.  Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives.

Authors:  Soo Jung Park; Won Ho Kim; Jae Hee Cheon
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 5.  The Same Intestinal Inflammatory Disease despite Different Genetic Risk Factors in the East and West?

Authors:  Rashid N S Lui; Siew C Ng
Journal:  Inflamm Intest Dis       Date:  2016-07-15

Review 6.  Changing epidemiological trends of inflammatory bowel disease in Asia.

Authors:  Wee Khoon Ng; Sunny H Wong; Siew C Ng
Journal:  Intest Res       Date:  2016-04-27

7.  Preoperative Corticosteroid Usage and Hypoalbuminemia Increase Occurrence of Short-term Postoperative Complications in Chinese Patients with Ulcerative Colitis.

Authors:  Ji Li; Hong Lyu; Hong Yang; Yue Li; Bei Tan; Ming-Ming Wei; Xi-Yu Sun; Jing-Nan Li; Bin Wu; Jia-Ming Qian
Journal:  Chin Med J (Engl)       Date:  2016-02-20       Impact factor: 2.628

8.  Family history and disease outcomes in patients with Crohn's disease: A comparison between China and the United States.

Authors:  Pei-Qi Wang; Jun Hu; Elie S Al Kazzi; Eboselume Akhuemonkhan; Min Zhi; Xiang Gao; Raquel Holand de Paula Pessoa; Sami Ghazaleh; Tuhina Cornelius; Suhel Abbas Sabunwala; Shadi Ghadermarzi; Kartikeya Tripathi; Mark Lazarev; Pin-Jin Hu; Susan Hutfless
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-11-06

9.  Underestimation of Smoking Rates in an East Asian Population with Crohn's Disease.

Authors:  Sung Wook Hwang; Hyungil Seo; Gwang-Un Kim; Eun Mi Song; Myeongsook Seo; Sang Hyoung Park; Eunja Kwon; Ho-Su Lee; Dong-Hoon Yang; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Jin-Ho Kim; Suk-Kyun Yang
Journal:  Gut Liver       Date:  2017-01-15       Impact factor: 4.519

10.  Initial medical and surgical management of inflammatory bowel disease in the biologic era: A comparison between the United States and China.

Authors:  Sanskriti Varma; Jun Hu; Ambar Mehta; Yiran Song; Angela Park; Min Zhi; Susan Hutfless
Journal:  JGH Open       Date:  2019-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.